Galvanize Therapeutics Patents – Insights & Stats (Updated 2023)

Galvanize Therapeutics has a total of 70 patents globally, out of which 14 have been granted. Of these 70 patents, more than 98% patents are active. The United States of America is where Galvanize Therapeutics has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Galvanize Therapeutics.

Galvanize Therapeutics was founded in 2022. Galvanize Therapeutics offers therapeutic goods and services to give healthcare solutions through its energy-based medical device technology. The company wants to lead the world in providing medical technology advances that stimulate biological processes to treat a variety of illnesses.

Do read about some of the most popular patents of Galvanize Therapeutics which have been covered by us in this article and also you can find Galvanize Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Galvanize Therapeutics patent portfolio.

How many patents does Galvanize Therapeutics have?

Galvanize Therapeutics has a total of 70 patents globally. These patents belong to 12 unique patent families. Out of 70 patents, 69 patents are active.

How Many Patents Did Galvanize Therapeutics File Every Year?

Galvanize Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGalvanize Therapeutics Applications FiledGalvanize Therapeutics Patents Granted
202327
2022164
2021172
2020151
20191
201812
20177

How many Galvanize Therapeutics patents are Alive/Dead?

Worldwide Patents

Galvanize Therapeutics Patent Portfolio

How Many Patents did Galvanize Therapeutics File in Different Countries?

Galvanize Therapeutics Worldwide Patent Filing

Countries in which Galvanize Therapeutics Filed Patents

CountryPatent
United States Of America15
Europe12
Australia12
Canada10
China9
Hong Kong (S.A.R.)4
Denmark2
Austria1
Japan1

 

Where are Research Centers of Galvanize Therapeutics Patents Located?

The Research Centers of GalvanizeTherapeutics Patents is the United States of America.

10 Best Galvanize Therapeutics Patents

US10702337B2, US20210393327A1 is the most popular patent in the Galvanize Therapeutics portfolio and it has received 7 citations.

Below is the list of 10 most cited patents of Galvanize Therapeutics:

Publication NumberCitation Count
US10702337B27
US20210393327A17
US20210236815A13
US20220133401A12
US20220104875A12
CN111683613A2
US11324543B21

What Percentage of Galvanize Therapeutics US Patent Applications Were Granted?

Galvanize Therapeutics (Excluding its subsidiaries) has filed 9 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 100%.

Below are the key stats of Galvanize Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Galvanize Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Wilson Sonsini Goodrich & Rosati9100%

What are Galvanize Therapeutics key innovation segments?

What Technologies are Covered by Galvanize Therapeutics?

The chart below distributes patents filed by Galvanize Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Galvanize Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Galvanize Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Galvanize Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.